Cycle Pharmaceuticals Ltd in Cambridge is seeking a Senior Clinical Study Manager to oversee the operational delivery ofPhase 3 trials and Phase 4 post-approval studies across rare diseases. The role is hybrid, with a minimum of three days in the Cambridge office, reporting to the Associate Director of Clinical Operations.
You will own studies from feasibility to final clinical study report, manage timelines, budgets and quality, and collaborate across cross-functional teams to ensure regulatory
#J-18808-Ljbffr
Senior Clinical Study Manager: Rare Diseases, Phase 3 Lead in Cambridge employer: Cycle Pharmaceuticals
Cycle Pharmaceuticals Ltd is an exceptional employer located in the vibrant city of Cambridge, offering a dynamic work culture that fosters innovation and collaboration in the field of rare diseases. Employees benefit from a supportive environment that prioritises professional growth, with opportunities to lead impactful projects that align with FDA standards. The hybrid work model enhances work-life balance, making it an ideal place for those seeking meaningful and rewarding careers in healthcare.
